• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
United States Pharmaceuticals and Healthcare Report Q1 2012 - Product Image

United States Pharmaceuticals and Healthcare Report Q1 2012

  • Published: January 2012
  • Region: United States
  • 95 Pages
  • Business Monitor International

FEATURED COMPANIES

  • Amgen
  • AstraZeneca
  • Eli Lilly
  • GlaxoSmithKline (GSK)
  • Leading Foreign Companies
  • Merck & Co
  • MORE

Business Monitor International's USA Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on the US pharmaceuticals and healthcare industry.

BMI View: Healthcare spending in the US will continue to account for a disproportionately large percentage of its GDP. Citizens of the world's largest economy are accustomed to regular health checkups, access to the latest diagnostics and therapeutics, choice of provider and outlet, insurance premium contributions from employers, a culture of end-of-life prolongation and extensive regulation. While this is not necessarily the 'best' form of healthcare, it is certainly the most expensive, both for individuals and the state.

Headline Expenditure Projections
- Pharmaceuticals: US$327.0bn in 2010 to US$331.3bn in 2011; +1.3% growth in local currency terms. BMIs forecast is unchanged from Q411.
- Healthcare: US$2,346bn in 2010 to US$2,449bn in 2011; 4.4% growth in local currency terms. BMIs forecast is unchanged from Q411.
- Medical devices:US$127.6bn READ MORE >

Executive Summary

SWOT Analysis
US Pharmaceuticals And Healthcare Industry SWOT
US Political SWOT
US Economic SWOT
US Business Environment SWOT

Pharmaceutical Business Environment Ratings
Table: Americas – Regional Pharmaceutical Business Environment Ratings, Q112
Rewards
Risks
US - Market Summary
Regulatory Regime
Innovative Drug Regulations
Generic Drug Regulations
Biosimilar Regulations
OTC Medicine Regulations
Medical Device Regulations
Promotion Regulations
Intellectual Property (IP) Regulations
Pricing & Reimbursement Environment
Part D

Industry Developments
Epidemiology
Healthcare Sector
Research and Development Sector
Clinical Trials
Contract/Clinical Research Organisations

Medical Device Industry
Industry Forecast Scenario
Overall Market Forecast
Table: Pharmaceutical Sales, 2007-2016
Key Growth Factors – Industry
Table: Healthcare Expenditure, 2007-2016

Macroeconomic Forecast Scenario
Prescription Drug Market Forecast
Table: Germany – Pharmaceutical Prescription Drug Sales, Historical Data and Forecast, 2007-2016
Table: Top 10 Therapeutic Classes By Sales (US$bn)
Table: Top 10 Therapeutic Classes By Dispensed Prescriptions (mn)
Patented Drug Market Forecast
Table: Patented Drug Sales, 2007-2016
Generic Drug Market Forecast
Table: Generic Drug Sales, 2007-2016
OTC Medicine Market Forecast
Table: OTC Medicine Sales, 2007-2016
Medical Device Market Forecast
Table: Medical Device Sales, 2007-2016
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade, 2008-2016

Key Risks to BMI's Forecast Scenario
Competitive Landscape
Research-Based Industry
Table: Top 10 Companies By US Prescription Sales (US$bn)
Table: Top 10 Drugs By US Sales (US$bn)
Research-Based Industry – Key Quarterly Developments
Generic Drugmakers
Table: Top 10 Companies By US Dispensed Prescriptions (mn)
Drug Distribution Sector
Pharmacy Retail Sector
Table: US Dispensed Prescription Drug Distribution By Channel Distribution Volume (mn)

Company Profiles
Leading Local Companies
Pfizer
Merck & Co
Eli Lilly
Amgen
Watson Pharmaceuticals
Leading Foreign Companies
GlaxoSmithKline (GSK)
AstraZeneca
Glossary

BMI Methodology
How We Generate Our Pharmaceutical Industry Forecasts
Pharmaceuticals Business Environment Ratings
Risk/Reward Ratings Methodology

Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Sources

- Pfizer
- Merck & Co
- Eli Lilly
- Amgen
- Watson Pharmaceuticals
- Leading Foreign Companies
- GlaxoSmithKline (GSK)
- AstraZeneca

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos